🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

55,55 USD

Máx. histórico

108,06

1032 días

Split 1:6 del 25/06/2013

Caída desde máximo

-48,59%

Rango 52 semanas

54,16 – 88,31

Variación hoy

-12,66%

Cierre anterior

63,60

Rango de hoy

54,16 – 60,84

Volumen hoy

6.774.495

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 15 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/03/2011 7,62 7,68 7,44 7,56 +0,00% 3,15% 28.267
21/03/2011 7,74 7,92 7,50 7,56 -1,56% 5,43% 61.817
18/03/2011 7,50 7,80 7,38 7,68 +2,40% 5,60% 62.983
17/03/2011 7,98 7,98 7,20 7,50 -5,30% 9,77% 128.767
16/03/2011 8,34 8,40 7,86 7,92 -5,04% 6,47% 144.367
15/03/2011 8,34 8,40 7,86 8,34 -2,80% 6,47% 66.483
14/03/2011 8,94 9,06 8,40 8,58 -5,92% 7,38% 72.967
11/03/2011 8,88 9,18 8,76 9,12 +2,70% 4,73% 61.417
10/03/2011 9,00 9,12 8,88 8,88 -1,33% 2,67% 44.633
09/03/2011 8,94 9,18 8,82 9,00 +0,00% 4,03% 45.500
08/03/2011 8,82 9,06 8,82 9,00 +1,35% 2,72% 58.150
07/03/2011 9,06 9,06 8,76 8,88 -2,63% 3,31% 52.517
04/03/2011 9,24 9,24 9,06 9,12 -1,30% 1,95% 54.133
03/03/2011 9,36 9,36 9,12 9,24 +0,00% 2,56% 72.600
02/03/2011 9,36 9,42 8,88 9,24 -1,91% 5,77% 94.800
01/03/2011 9,60 9,72 9,18 9,42 +0,00% 5,63% 136.583
28/02/2011 9,18 9,42 9,06 9,42 +2,61% 3,92% 242.617
25/02/2011 9,18 9,30 9,06 9,18 +0,66% 2,61% 62.533
24/02/2011 8,88 9,12 8,88 9,12 +3,40% 2,70% 104.533
23/02/2011 8,70 9,00 8,64 8,82 +2,08% 4,14% 65.117
22/02/2011 9,12 9,18 8,64 8,64 -5,26% 5,92% 118.783
18/02/2011 9,18 9,36 8,82 9,12 +1,33% 5,88% 151.650
17/02/2011 9,48 9,54 8,88 9,00 -3,85% 6,96% 212.833
16/02/2011 10,02 10,20 9,24 9,36 -6,59% 9,58% 167.383
15/02/2011 10,98 10,98 9,96 10,02 -8,74% 9,29% 226.867
14/02/2011 11,22 11,28 10,86 10,98 +1,10% 3,74% 70.250
11/02/2011 10,80 10,98 10,68 10,86 +0,00% 2,78% 68.267
10/02/2011 11,04 11,28 10,68 10,86 -1,63% 5,43% 100.900
09/02/2011 11,34 11,52 10,98 11,04 -1,08% 4,76% 70.700
08/02/2011 11,16 11,40 11,16 11,16 +0,00% 2,15% 31.467